MedPath

Investigation of the safety of ventilation with Ventrain in patients during a planned operatio

Withdrawn
Conditions
Study of the safety of ventilation through a narrow tube during operation
10046304
Registration Number
NL-OMON40890
Lead Sponsor
Orbis Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

- ASA 1-2
- Planned for operation from orthopaedic, gynaecology or ENT
- Aged above 18 years and under 65

Exclusion Criteria

- ASA more than 2
- Aged under 18
- Aged above 65
- Respiratory disease
- Cardiovascular disease
- Smokers
- Obese patients
- Pregnancy

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>- Demonstrate the safety and efficacy of ventilation with Ventrain® during 5<br /><br>minutes. Safety is demonstrated if the peak pressure during insufflation does<br /><br>not exceed 25 mm H2O and PEEP is not smaller than -5 mm H2O and not higher than<br /><br>6 mm H2O. The number of interventions from the safety-person dr. C will be the<br /><br>primary endpoint. We assume that the interventionrate will be less than 15%.<br /><br><br /><br>Powercalculation<br /><br>As this can be seen as a pilot study and no information is available at this<br /><br>moment.<br /><br>However. the primary outcome is the number of interventions from the<br /><br>safety-person dr. C . We assume that this will be less than 15%. With 20<br /><br>patients we can exclude the possibility that this failure proportion is higher<br /><br>than 13.9%. One sided tested the CI will be less than 13.9%. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Measure the different parameters during ventilation with the Ventrain® as there<br /><br>are lung pressure, peak lung pressure, PEEP, capno, oxygen saturation, tension<br /><br>and heart rhythm.</p><br>
© Copyright 2025. All Rights Reserved by MedPath